Automatically clustered newsroom coverage around one of the most active themes in the intellectual property ecosystem.
The U.S. Supreme Court has granted certiorari in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. to resolve whether generic drug makers’ marketing statements can support inducement claims of patent infringement when using skinny labels that omit patented uses. The case tests the boundaries of Hatch-Waxman’s Sect…
In a significant ruling on patent infringement, the Madras High Court dismissed a suit filed by an independent inventor against Ashok Leyland and others, finding no infringement of a patent related to an electrically operated vehicle with wind-powered battery charging. The Court held that the defendants’ battery swapp…
In a notable decision on January 26, 2022, the U.S. District Court for the Northern District of Illinois held that patent infringement claims and injunctive relief are available to reference product sponsors during the second phase of Biosimilar Price Competition and Innovation Act litigation. The ruling clarifies tha…
Subscribe to receive daily and weekly newsroom coverage aligned to this trend cluster and adjacent IP developments.